La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Oncternal Therapeutics a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Oncternal Therapeutics..

Oncternal Therapeutics (NASDAQ:ONCT) Azioni, Catena delle Opzioni

Oncternal Therapeutics

Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need. The Company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to ROR1 (Receptor-tyrosine kinase-like Orphan Receptor 1), and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoprotein. The Company is also developing ONCT-808, a CAR-T (chimeric antigen receptor T-cells) product candidate that target ROR1, and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. The Company has one operating segment in the United States.

Oncternal Therapeutics, Inc. - Common Stock

Oncternal Therapeutics Inc

Morgan Stanley analyst David Arcaro maintains Consolidated Edison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ED#NYSE">ED</a>) with a Underweight and lowers the price target from $88 to $85.

News

Price Target

Analyst Ratings

Morgan Stanley Maintains Underweight on Consolidated Edison, Lowers Price Target to $85

TD Cowen analyst Andrew Sherman maintains Procore Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCOR#NYSE">PCOR</a>) with a Buy and raises the price target from $70 to $82.

PCOR

TD Cowen Maintains Buy on Procore Technologies, Raises Price Target to $82

Jefferies analyst Brent Thill maintains Procore Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCOR#NYSE">PCOR</a>) with a Hold and raises the price target from $70 to $80.

Jefferies Maintains Hold on Procore Technologies, Raises Price Target to $80

On Wednesday, the Department of Justice released its remedy requests aimed at curbing Google&#8217;s search engine dominance. Alphabet, Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google responded that the proposed remedies were "staggering." Analysts are sharing their <a href="https://www.benzinga.com/government/regulations/24/11/42119020/alphabet-bleeds-over-120-billion-in-market-value-eyes-worst-day-in-10-months-after-doj-demands-google-chrome-sale">reactions as well. </a>
<ul>
<li>BMO Capital Markets analyst Brian Pitz reiterated an Outperform rating on Alphabet and kept the price target at $217.</li>
<li>JPMorgan analyst Doug Anmuth maintains Alphabet with an Overweight rating and raised the price target to $212.</li>
<li>Goldman Sachs analyst Eric Sheridan maintained a Buy rating and kept the price target at $210.</li>
</ul>
Read More: <a href="https://www.benzinga.com/general/social-media/24/11/42119493/rumble-eyes-buying-bitcoin-could-it-be-the-next-microstrategy">Rumble CEO Considers Bitcoin Investment, Engages Michael Saylor As Shares Rally</a>
Pitz described the sweeping remedies proposed by the DOJ as a "kitchen sink moment.&#8221; Pitz noted that the DOJ's proposed remedies extend past Google's search distribution partnerships with Apple and Samsung and included the company's AI search-based investments. 
Anmuth echoed similar sentiments regarding the "very comprehensive" set of remedies proposed by the DOJ. He said parts of the remedies are "more punitive than expected" and listed those around consumer choice limitations and the syndication of search data and ads as examples. 
The DOJ's proposal should represent the worst-case scenario for Google, reminded Anmuth. He expects Google's proposed final remedies to be much more modest.&nbsp;
"Ultimately, we believe the judge's final decision next summer will be more balanced … and will likely have greater consideration around the potential negative impact to users," the JPMorgan analyst wrote.&nbsp;
Sheridan said the firm does not take a view on a potential outcome of the case. He noted, however, that leadership at the US DOJ will change in January with the incoming Trump administration which adds an additional variable to the potential outcomes of the trial. 
The analyst also pointed to recent comments from President-elect Donald Trump expressing skepticism on a potential break-up of Google.&nbsp;
"If you do that, are you going to destroy the company? What you can do without breaking it up is make sure it&#8217;s more fair,&#8221; Trump said in October, per Reuters.&nbsp;
Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Alphabet shares are down 1.55% at $166.62 at the time of publication Friday. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/etfs/24/11/42044642/trump-appears-frustrated-as-elon-musk-chimes-in-on-treasury-secretary-adds-more-names-to-a-list-of-potential-picks">Trump Appears &#8216;Frustrated&#8217; As Elon Musk Chimes In On Treasury Secretary, Adds More Names To Short List&nbsp;</a></li>
</ul>
Image:&nbsp;Simon from Pixabay

Analyst Color

Government

Large Cap

Regulations

Reiteration

Legal

Movers

Tech

GOOG

GOOGL

'Staggering' Google Breakup Proposal From DOJ A 'Kitchen Sink Moment': Alphabet Analyst

Morgan Stanley analyst David Arcaro maintains CenterPoint Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNP#NYSE">CNP</a>) with a Equal-Weight and lowers the price target from $32 to $31.

Morgan Stanley Maintains Equal-Weight on CenterPoint Energy, Lowers Price Target to $31

"The signs are all pointing in the right direction. Let's just hope the speed picks up," says Josh Schiller, a partner at Boies Schiller Flexner, speaking about the progression of a Massachusetts-based lawsuit that could reshape the cannabis industry. The case challenges the federal government's enforcement of the Controlled Substances Act (CSA) against state-legal cannabis businesses, arguing that the federal approach violates constitutional principles.
At the center of the lawsuit is Justice Clarence Thomas' critique of federal cannabis policy. In 2021, Thomas called the federal government's stance "half in, half out," highlighting its contradictory approach to state-legal cannabis markets. Schiller's team argues that these contradictions undermine the rationale of the Supreme Court's 2005 decision in Gonzales v. Raich, which upheld federal authority under the Commerce Clause.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Josh Schiller Breaks Down Landmark Cannabis Lawsuit &amp; Federal Reform Implications &#x7C; Cultivated Live" width="500" height="281" src="https://www.youtube.com/embed/E6Ws42CkS5k?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
<h3 class="wp-block-heading">A New Era Of Legal Challenges</h3>
Filed in Massachusetts, the case seeks to address what Schiller describes as a fundamental shift in federal cannabis policy. In Raich, the federal government successfully argued that a consistent national prohibition was necessary to combat the illicit market. However, Schiller points to subsequent federal actions, such as congressional riders protecting state medical cannabis programs, as evidence that the government has abandoned its eradication strategy.
"Congress has taken steps to move away from the eradication policy," Schiller explains during the interview. He cites examples like the federal allowance of recreational cannabis sales in Washington, D.C., to show that federal priorities have evolved.
The lawsuit also addresses the practical challenges faced by cannabis businesses operating under the shadow of federal prohibition. "The financial consequences imposed by the federal government's continued overhang of illegality has consequences," Schiller says. He highlights issues such as excessive taxation under IRS Code 280E, limited access to banking and loans, and the reliance on cash-based operations due to federal banking restrictions.
<h3 class="wp-block-heading">Stakes For The Industry</h3>
If successful, the lawsuit could remove significant barriers for cannabis businesses, including the tax penalties imposed by 280E. "Everyone in this industry knows the taxation is discriminatory," Schiller notes, referring to how cannabis businesses are taxed on revenue rather than profit.
The case could also open the door to retroactive tax refunds, potentially worth billions, and pave the way for broader financial reforms. Schiller acknowledges that these changes could have transformative effects on the industry, leveling the playing field for businesses operating within state-legal frameworks.
<h3 class="wp-block-heading">What's Next?</h3>
Oral arguments in the U.S. Court of Appeals for the First Circuit are scheduled for December 5, 2024. Schiller explains that the court could either uphold the government's motion to dismiss or allow the case to proceed. If the plaintiffs are unsuccessful, the next step would be petitioning the Supreme Court to hear the case, although Schiller acknowledges that the Court takes on a limited number of cases.
"They're very selective," Schiller says of the Supreme Court. "They hear a very small single-digit percentage of the cases that they take on." However, Schiller believes the case could have appeal for some justices, particularly those like Justice Thomas, who have previously critiqued federal cannabis policy. &#8220;We also believe that Justice Gorsuch, who's a well-known author of federalist principles, would be interested in a case like this,&#8221; he adds.
Schiller emphasizes that a favorable ruling could fundamentally alter how the federal government interacts with state-regulated cannabis markets, potentially setting a precedent for other industries navigating federal-state conflicts.
<h3 class="wp-block-heading">A Pivotal Moment For Federalism</h3>
As the case moves forward, its implications extend beyond cannabis, touching on larger questions of federalism and constitutional authority. Schiller stresses the need for the courts to reassess how federal policies align with state-legal frameworks.
The plaintiffs argue that the federal government's continued criminalization of cannabis businesses operating lawfully under state laws creates unnecessary and discriminatory burdens, from excessive taxation to restricted access to financial services.
Schiller's team views the lawsuit as a step toward bridging the gap between federal actions and the progress made by states in regulating cannabis markets. The outcome could shape the future of cannabis policy in America, offering much-needed clarity for businesses and regulators alike.

Cannabis

Politics

VRNOF

Challenging Cannabis Prohibition: Lawyer Behind Same-Sex Marriage Takes On Federal Policy, Citing Justice Thomas' Critique

TD Cowen analyst John Kernan maintains TJX Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>) with a Buy and raises the price target from $130 to $132.

TD Cowen Maintains Buy on TJX Companies, Raises Price Target to $132

Morgan Stanley analyst Stephen Byrd maintains CMS Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMS#NYSE">CMS</a>) with a Equal-Weight and lowers the price target from $69 to $67.

Morgan Stanley Maintains Equal-Weight on CMS Energy, Lowers Price Target to $67

Jefferies analyst Brent Thill maintains Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Buy and raises the price target from $110 to $135.

ESTC

Jefferies Maintains Buy on Elastic, Raises Price Target to $135

Contracts

General Dynamics' Gulfstream Aerospace Secures $991M Contract to Provide Logistics Support for U.S. Military Aircraft Fleets Over Seven Years

China Renaissance analyst Yiming Wang upgrades XPeng (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) from Hold to Buy and announces $16.7 price target.

Upgrades

XPEV

China Renaissance Upgrades XPeng to Buy, Announces $16.7 Price Target

High-rolling investors have positioned themselves bullish on Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in MNDY often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 10 options trades for Monday.Com. This is not a typical pattern.
The sentiment among these major traders is split, with 50% bullish and 30% bearish. Among all the options we identified, there was one put, amounting to $28,350, and 9 calls, totaling $611,070.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $230.0 to $350.0 for Monday.Com over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Monday.Com stands at 463.89, with a total volume reaching 414.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Monday.Com, situated within the strike price corridor from $230.0 to $350.0, throughout the last 30 days.
<h3>Monday.Com 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732295765_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MNDY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$9.0</td>
<td>$5.1</td>
<td>$9.0</td>
<td>$275.00</td>
<td>$270.0K</td>
<td>1.3K</td>
<td align="right">0</td>
</tr>
<tr>
<td>MNDY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$36.9</td>
<td>$34.6</td>
<td>$35.3</td>
<td>$260.00</td>
<td>$70.6K</td>
<td>589</td>
<td align="right">23</td>
</tr>
<tr>
<td>MNDY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$12.7</td>
<td>$12.0</td>
<td>$12.5</td>
<td>$300.00</td>
<td>$58.7K</td>
<td>360</td>
<td align="right">29</td>
</tr>
<tr>
<td>MNDY</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$60.7</td>
<td>$57.4</td>
<td>$59.0</td>
<td>$230.00</td>
<td>$47.2K</td>
<td>154</td>
<td align="right">8</td>
</tr>
<tr>
<td>MNDY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$41.2</td>
<td>$39.4</td>
<td>$41.2</td>
<td>$250.00</td>
<td>$41.2K</td>
<td>1.3K</td>
<td align="right">10</td>
</tr>
</tbody>
</table>

<h3>About Monday.Com</h3>
Monday.com is a provider of work management software delivered via a cloud-based software-as-a-service, or SaaS model. The firm's solutions offer flexible and highly customizable tools to digitize business processes across countless use cases. Monday's offering supports workflow management across departments, real-time visibility and accountability, and automation capabilities. Monday also offers prepackaged CRM and DevOps management solutions, in addition to standalone survey and digital whiteboard tools. As of 2023, Monday served over 225,000 customers in more than 200 countries.
Following our analysis of the options activities associated with Monday.Com, we pivot to a closer look at the company's own performance.
<h3>Current Position of Monday.Com</h3>
<ul>
<li>With a volume of 607,390, the price of MNDY is up 0.82% at $278.52. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 80 days.</li>
</ul>
<h3>Expert Opinions on Monday.Com</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $320.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Overweight rating for Monday.Com, targeting a price of $330. 
&#x2A; Reflecting concerns, an analyst from DA Davidson lowers its rating to Neutral with a new price target of $300. 
&#x2A; An analyst from Needham persists with their Buy rating on Monday.Com, maintaining a target price of $350. 
&#x2A; An analyst from Piper Sandler has decided to maintain their Overweight rating on Monday.Com, which currently sits at a price target of $350. 
&#x2A; Maintaining their stance, an analyst from Baird continues to hold a Neutral rating for Monday.Com, targeting a price of $270. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Monday.Com, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

MNDY

A Closer Look at Monday.Com's Options Market Dynamics

Whales with a lot of money to spend have taken a noticeably bearish stance on Vistra.
Looking at options history for Vistra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) we detected 17 trades.
If we consider the specifics of each trade, it is accurate to state that 29% of the investors opened trades with bullish expectations and 58% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $57,000 and 15, calls, for a total amount of $691,634.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $105.0 and $165.0 for Vistra, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of Vistra stands at 808.8, with a total volume reaching 695.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Vistra, situated within the strike price corridor from $105.0 to $165.0, throughout the last 30 days.
<h3>Vistra Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732295760_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$15.9</td>
<td>$15.2</td>
<td>$15.45</td>
<td>$150.00</td>
<td>$69.5K</td>
<td>4.1K</td>
<td align="right">78</td>
</tr>
<tr>
<td>VST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/27/24</td>
<td>$23.6</td>
<td>$22.9</td>
<td>$23.04</td>
<td>$140.00</td>
<td>$68.5K</td>
<td>39</td>
<td align="right">31</td>
</tr>
<tr>
<td>VST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$59.2</td>
<td>$57.7</td>
<td>$58.24</td>
<td>$105.00</td>
<td>$58.2K</td>
<td>11</td>
<td align="right">10</td>
</tr>
<tr>
<td>VST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/27/24</td>
<td>$20.7</td>
<td>$19.1</td>
<td>$19.25</td>
<td>$145.00</td>
<td>$57.6K</td>
<td>64</td>
<td align="right">30</td>
</tr>
<tr>
<td>VST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$11.4</td>
<td>$11.0</td>
<td>$11.4</td>
<td>$150.00</td>
<td>$51.3K</td>
<td>258</td>
<td align="right">86</td>
</tr>
</tbody>
</table>

<h3>About Vistra</h3>
Vistra Energy is one of the largest power producers and retail energy providers in the US Following the 2024 Energy Harbor acquisition, Vistra owns 41 gigawatts of nuclear, coal, natural gas, and solar power generation along with one of the largest utility-scale battery projects in the world. Its retail electricity business serves 5 million customers in 20 states, including almost a third of all Texas electricity consumers. Vistra emerged from the Energy Future Holdings bankruptcy as a stand-alone entity in 2016. It acquired Dynegy in 2018.
After a thorough review of the options trading surrounding Vistra, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Vistra</h3>
<ul>
<li>With a trading volume of 3,663,193, the price of VST is down by -3.59%, reaching $160.63.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 96 days from now.</li>
</ul>
<h3>What The Experts Say On Vistra</h3>
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $147.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from BMO Capital keeps a Outperform rating on Vistra with a target price of $147. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Vistra, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Unpacking the Latest Options Trading Trends in Vistra

Morgan Stanley analyst Stephen Byrd maintains Atmos Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATO#NYSE">ATO</a>) with a Overweight and lowers the price target from $145 to $143.

Morgan Stanley Maintains Overweight on Atmos Energy, Lowers Price Target to $143

Financial giants have made a conspicuous bullish move on Lemonade. Our analysis of options history for Lemonade (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>) revealed 20 unusual trades.
Delving into the details, we found 70% of traders were bullish, while 20% showed bearish tendencies. Out of all the trades we spotted, 11 were puts, with a value of $1,950,705, and 9 were calls, valued at $1,190,845.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $15.0 to $55.0 for Lemonade during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Lemonade's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Lemonade's substantial trades, within a strike price spectrum from $15.0 to $55.0 over the preceding 30 days.
<h3>Lemonade Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732295755_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LMND</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$4.6</td>
<td>$3.7</td>
<td>$4.3</td>
<td>$49.00</td>
<td>$460.2K</td>
<td>5.0K</td>
<td>1.2K</td>
</tr>
<tr>
<td>LMND</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$4.1</td>
<td>$3.6</td>
<td>$3.8</td>
<td>$49.00</td>
<td>$440.0K</td>
<td>5.0K</td>
<td>2.7K</td>
</tr>
<tr>
<td>LMND</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$38.6</td>
<td>$38.5</td>
<td>$38.6</td>
<td>$15.00</td>
<td>$386.0K</td>
<td>84</td>
<td>275</td>
</tr>
<tr>
<td>LMND</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$38.7</td>
<td>$38.6</td>
<td>$38.7</td>
<td>$15.00</td>
<td>$263.1K</td>
<td>84</td>
<td>275</td>
</tr>
<tr>
<td>LMND</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$2.65</td>
<td>$2.55</td>
<td>$2.55</td>
<td>$48.00</td>
<td>$250.5K</td>
<td>91</td>
<td>3.6K</td>
</tr>
</tbody>
</table>

<h3>About Lemonade</h3>
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.
<h3>Present Market Standing of Lemonade</h3>
<ul>
<li>With a volume of 2,396,176, the price of LMND is up 0.08% at $50.4. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 95 days.</li>
</ul>
<h3>Expert Opinions on Lemonade</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $33.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Piper Sandler persists with their Neutral rating on Lemonade, maintaining a target price of $44. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Neutral rating for Lemonade, targeting a price of $25. 
&#x2A; An analyst from Morgan Stanley persists with their Underweight rating on Lemonade, maintaining a target price of $23. 
&#x2A; An analyst from BMO Capital persists with their Underperform rating on Lemonade, maintaining a target price of $15. 
&#x2A; Consistent in their evaluation, an analyst from JMP Securities keeps a Market Outperform rating on Lemonade with a target price of $60. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Lemonade options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

LMND

Behind the Scenes of Lemonade's Latest Options Trends

Institutional investment in the cryptocurrency space is poised for a massive influx, with hundreds of billions of dollars expected to <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42138947/bitcoin-zeroes-in-on-100000-but-this-indicator-signals-one-more-brief-correction">enter the market</a> in the coming years, according to Devin Ryan, managing director at JMP Securities.
What Happened: In an <a href="https://www.cnbc.com/video/2024/11/22/crypto-boom-drives-investment-opportunities-with-coinbase-and-robinhood-leading-the-charge.html">interview</a> with CNBC, Ryan emphasized that the evolving regulatory landscape and the increasing acceptance of Bitcoin exchange-traded funds (ETFs) are key catalysts for this transformative growth.
"We have research out saying $220 billion of assets are coming into Bitcoin ETFs in the next three years," Ryan said. "If there is a strategic reserve, that could be hundreds of billions of dollars of assets into Bitcoin."
Ryan pointed out that trading volumes for companies like Coinbase Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) and Robinhood (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) have surged since the U.S. presidential election. 
Coinbase volumes, for instance, have tripled, reflecting growing interest in the sector. 
"This activity unlocks a lot of innovation that's been held back," Ryan said, noting the potential for significant growth in payments, remittances, stablecoins, and Web3 applications.
Sarah Kunst, managing director at Cleo Capital, echoed Ryan's optimism, noting that institutional money has been waiting on the sidelines for regulatory clarity. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42138209/microstrategy-trading-at-insane-256-premium-to-bitcoin-holdings-research-shows">MicroStrategy Trading At &#8216;Insane&#8217; 256% Premium To Bitcoin Holdings, Research Shows</a>
Kunst highlighted the new U.S. administration&#8217;s potentially more favorable stance toward mergers and acquisitions (M&amp;A) as a driver for ecosystem growth. 
"I think there are people who have not yet gotten in the game who want to get in the game," she said. "This is really crypto's third act."
Kunst identified key players in the space, including crypto exchanges and infrastructure firms, as potential acquisition targets for larger financial institutions. 
"Names like FalconX, the crypto prime brokerage, and Gemini, the crypto marketplace, are likely to attract attention from big acquirers," she stated.
While Bitcoin CRYPTO: BTC) remains the centerpiece of institutional interest, Kunst sees a broadening investment focus. "Meme coins are dangerous—you can make a lot, but you can lose your shirt," she warned. 
Instead, she pointed to stablecoins and cryptocurrency ETFs as safer options, especially for institutions unable to hold crypto directly.
Ryan reinforced this outlook, emphasizing the importance of capital flows. 
"Follow the flows, and the flows are still coming—we're in the early days," he said. 
Beyond Bitcoin ETFs, Ryan expects tens of billions of dollars to flow into other crypto tokens as regulatory uncertainty diminishes, spurring innovation and further investment in the space.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42136031/charles-schwab-prepares-for-spot-cryptocurrency-trading-under-new-leadership">Charles Schwab Prepares For Spot Cryptocurrency Trading Under New Leadership</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

COIN

HOOD

Bitcoin ETFs Will See Hundreds Of Billions In Inflows, Analyst Predicts

Shaquille O&#8217;Neal is one of the most famous and successful people around, but when it comes to his fortune, he&#8217;s surprisingly relaxed about it. On a recent Dan Patrick Show, Dan asked the NBA legend if he's a billionaire yet and his response was classic Shaq. He casually replied, &#8220;I don&#8217;t know, I never checked.&#8221;
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/advisor-adv-warren-buffett">Warren Buffett Flipped His Neighbor's $67,000 Life Savings Into A $50 Million Fortune — This Would Be Worth Over $500 Million Today</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li><a href="https://www.benzinga.com/money/cd-valet-growth">CD Popularity Soars: Over 50 Million Americans Embrace Safe Savings with 5–10% Annual Growth</a></li>
</ul>
Instead of closely monitoring his bank balance like many other wealthy individuals, Shaq measures wealth differently. To him, being rich isn't about hitting a specific dollar amount but about being able to take care of his family – <a href="https://www.benzinga.com/personal-finance/24/10/41186647/nba-star-shaq-wanted-to-get-rich-to-buy-his-mother-anything-she-wanted-that-right-there-is-what-">especially his mom</a>.
When a kid recently asked Shaq how it feels to be rich, he gave a heartfelt answer: &#8220;My definition of rich is being able to buy my mother whatever she wants – my favorite person in the world.&#8221; For Shaq, taking care of his mother, who made countless sacrifices when he was growing up, is the ultimate sign of wealth.
In the interview, Shaq recalled moments he'd never forget – <a href="https://www.benzinga.com/personal-finance/24/10/41337452/nba-legend-shaq-was-raised-by-teen-mom-who-fueled-his-success-cant-outplay-me-because-if-you-are">seeing his mom struggle</a>, even wearing the same pair of pants multiple days a week just to make ends meet. That's why, when he started making money, one of his first goals was to ensure his mom never had to struggle again. She was the first person he thought of when he got his big NBA paycheck.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">.<a href="https://twitter.com/SHAQ?ref_src=twsrc%5Etfw">@Shaq</a> shares what his definition of being "rich" is. <a href="https://t.co/5ydPVEhGfB">pic.twitter.com/5ydPVEhGfB</a>
&mdash; Dan Patrick Show (@dpshow) <a href="https://twitter.com/dpshow/status/1857147741824278590?ref_src=twsrc%5Etfw">November 14, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: ‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a>
Shaq's motivation comes from seeing his mom's sacrifices and ensuring she's always comfortable. "As long as my mother doesn't have to feel like she felt when we were young, that's my definition of being rich," he said.
Shaq's big heart doesn't stop with his mom. He shared a recent story about being at Walmart, where he spotted a mom with a tall son and three young daughters. The mom was picking out items for her kids and Shaq approached her, asking how much she planned to spend. After learning she was buying only what she could afford, he gave her $5,000 to get everything she needed for her family. Moments like these show what matters most to Shaq – using his money to make life better for others.
Shaq also wants his kids to learn these values. He wants them to understand that just because he has a lot of money doesn't mean they can rely on it without effort. For this reason, he has made it clear that his children must earn a share of his money by becoming good students, <a href="https://www.benzinga.com/personal-finance/24/11/41869301/shaqs-got-a-500-million-fortune-but-his-kids-arent-getting-a-dime-without-earning-it-you-need-3-degrees-to-touch-daddys-cheese">getting multiple diplomas</a> and demonstrating their ability to work hard on their own.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
</ul>

Personal Finance

Shaquille O'Neal Says He Doesn't Know If He's A Billionaire Yet – 'I Never Checked.' Here's What Being Rich Means To Him

Morgan Stanley analyst Stephen Byrd maintains American Electric Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEP#NASDAQ">AEP</a>) with a Overweight and lowers the price target from $109 to $104.

Morgan Stanley Maintains Overweight on American Electric Power, Lowers Price Target to $104

For decades, famed value investor&nbsp;Warren Buffett&nbsp;has insisted&nbsp;that he does not try to <a href="https://www.benzinga.com/personal-finance/24/04/38275323/warren-buffett-warns-dont-watch-the-market-closely-urges-not-to-obsessively-check-stock-prices-i">&#8220;time the market.&#8221;</a> But, his recent sales could serve as a warning sign for investors amid a period of protracted valuations.
What Happened: Buffett&#8217;s Berkshire Hathaway Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) has gradually wound down its largest positions over the last year.
Berkshire <a href="https://www.benzinga.com/markets/equities/24/11/41993666/warren-buffetts-berkshire-hathaway-slashes-apple-bofa-holdings-adds-dominos-pizza-in-q3">slashed its largest position</a> in Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) by over two-thirds since 2023. Buffett also sold much of his position in Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) since the summer. He also trimmed back nearly all of his position in Ulta Beauty Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>), an atypically short holding period for the investor who preaches investing for the long term.
The Omaha, Nebraska-based company&#8217;s cash horde now stands at an astounding $325 billion.
See Also: <a href="https://www.benzinga.com/markets/equities/24/11/42137295/as-mstrs-michael-saylor-says-warren-buffett-is-destroying-berkshire-capital-analyst-suggests-ove">As MSTR&#8217;s Michael Saylor Says Warren Buffett Is &#8216;Destroying&#8217; Berkshire Capital, Analyst Suggests &#8216;Overpriced…Hot Stock Market&#8217; Could Be The Reason Oracle Of Omaha Is Sitting On $325B Cash</a>
Why it Matters: Several market experts have struggled to comprehend Buffett&#8217;s thought process — is he bearish on the market at large? Reallocating his portfolio away from Apple and Bank of America to diversify? Or, as Buffett hinted at in May, anticipating a future change to U.S. tax laws?
An <a href="https://www.bloomberg.com/opinion/articles/2024-11-21/buffett-s-325-billion-cash-hoard-is-an-early-warning-signal?srnd=homepage-americas">article</a> from Bloomberg columnist Nir Kaissar could fuel the first theory. A <a href="https://x.com/cullenroche/status/1859644225991987508">post</a> on X relayed a graph from the article showing Buffett&#8217;s cash pile conspicuously rising ahead of financial crises.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Interesting piece here from <a href="https://twitter.com/markets?ref_src=twsrc%5Etfw">@markets</a> and how Buffett's cash hoard often spikes before equity market slowdowns. &#x1f914;&#x1f914;&#x1f914; <a href="https://t.co/9aFmsMpP2N">pic.twitter.com/9aFmsMpP2N</a>
&mdash; Cullen Roche (@cullenroche) <a href="https://twitter.com/cullenroche/status/1859644225991987508?ref_src=twsrc%5Etfw">November 21, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<figcaption class="wp-element-caption">The company&#8217;s cash allocation ticked upwards ahead of two large market crashes in 2000 and 2008.</figcaption></figure>
As companies in the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) sustain a period of high valuations, Buffett could simply be heeding his advice, &#8220;to be fearful when&nbsp;others are greedy&nbsp;and to be greedy only when others are fearful,&#8221; allocating his portfolio away from what he deems riskier investments
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42140842/sp-500-faces-volatile-2025-as-inflation-boom-could-return-bank-of-america-strategist">S&amp;P 500 Faces Volatile 2025 As &#8216;Inflation Boom&#8217; Could Return: Bank Of America Strategist</a></li>
</ul>
Photo: Shutterstock

Equities

AAPL

ULTA

Warren Buffett Claims To Not 'Time The Market,' But His Cash Horde Tells A Different Story

Jefferies analyst Brent Thill maintains Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) with a Buy and raises the price target from $790 to $800.

INTU

Jefferies Maintains Buy on Intuit, Raises Price Target to $800

Oncternal Therapeutics Q2 2024 Earnings Preview

Oncternal Therapeutics GAAP EPS of -$2.89 beats by $0.14, revenue of $0.8M beats by $0.64M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Oncternal Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/onct-stock-quote/">ONCT</a>) just reported results for the second quarter of 2024.<ul><li>Oncternal Therapeutics reported earnings per share of -$2.89. This was above the analyst estimate for EPS of -$3.10.</li><li>The company reported revenue of $801,000.</li><li>This was 233.75% better than the analyst estimate for revenue of $240,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/onct-stock-earnings-oncternal-therapeutics-for-q2-of-2024/">ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

ONCT Stock Earnings: Oncternal Therapeutics Beats EPS, Beats Revenue for Q2 2024

Oncternal Therapeutics, Inc. (ONCT) Q2 2024 Earnings Call Transcript

Oncternal plunges on portfolio shakeup

Oncternal Therapeutics ( ($ONCT) ) has shared an announcement. Oncternal Therapeutics, Inc. is reducing its workforce by 37%, approximately 10 empl...

Oncternal Therapeutics Restructures Amid Clinical Setbacks

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include:&nbsp...

Biotech Alert: Searches spiking for these stocks today

Oncternal Therapeutics (ONCT) has disclosed a new risk, in the Employment / Personnel category. Oncternal Therapeutics faces potential risks associ...

Oncternal Therapeutics Faces Workforce Reduction Challenges: Potential Risks and Implications

Oncternal Therapeutics ( ($ONCT) ) has provided an update. Oncternal Therapeutics, Inc. is undergoing a significant workforce reduction, effective ...

Oncternal Therapeutics Announces Workforce Reduction and Executive Changes

Oncternal Therapeutics ( ($ONCT) ) has released its Q3 earnings. Here is a breakdown of the information Oncternal Therapeutics presented to its inv...

Oncternal Therapeutics Reports Q3 2024 Earnings

ALLK

APVO

CNSP

CYCC

GNPX

IMUX

MBIO

ONCT

SYRS

Press Releases

Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Oncternal Therapeutics to Provide Business Update and Report First Quarter 2024 Financial Results

Earnings

Oncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results

Health Care

Oncternal Announces Enrollment Completed and Dosing Initiated for Fifth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

Oncternal Therapeutics to Present in JonesTrading Healthcare Summit

Oncternal Announces Enrollment Completed and Dosing Initiated for Sixth Dose Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2024 Financial Results

Oncternal Therapeutics Provides Business Update and Announces Second Quarter 2024 Financial Results

General

Oncternal Therapeutics Announces Termination of its Clinical Studies and Exploration of Strategic Alternatives

Oncternal Therapeutics Announces Updated Safety and Efficacy Data for Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer

Comments

Oncternal Therapeutics

Oncternal Therapeutics (ONCT) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO